Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003168018 | SCV003861265 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2023-07-07 | criteria provided, single submitter | clinical testing | The c.652-116A>G intronic variant results from an A to G substitution 116 nucleotides upstream from coding exon 8 in the LZTR1 gene. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will result in the creation or strengthening of a novel splice donor site; however, direct evidence is insufficient at this time (Ambry internal data). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003466030 | SCV004193679 | uncertain significance | Schwannomatosis 2 | 2024-01-22 | criteria provided, single submitter | clinical testing |